{"id":"W1608594180","doi":"10.1111/j.1468-3083.2011.04225.x","title":"Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: results of PRIDE, an open‐label, multicentre, phase IIIb study","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lynde Centre for Dermatology; University of British Columbia; Abbott (Canada); Probity Medical Research","funders":"Abbott Laboratories","keywords":"Medicine; Adalimumab; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Internal medicine; Plaque psoriasis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00667072,0.001296075,0.002443565,0.0003963936,0.0006187016,0.00120847,0.0009963628,0.00151964,0.001697192],"category_scores_gemma":[0.00283788,0.0006326818,0.002004478,0.00045677,0.0009613805,0.0007607355,0.0003179868,0.003838534,0.0005532979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00135915,"about_ca_system_score_gemma":0.002024068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002552347,"about_ca_topic_score_gemma":0.003808626,"domain_scores_codex":[0.9981564,0.0009861778,0.0000970677,0.0001914137,0.0003713233,0.0001975475],"domain_scores_gemma":[0.9971231,0.000678563,0.0006700628,0.0002850248,0.00033995,0.0009033082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8068007,0.07557488,0.01014618,0.0008298332,0.002834002,0.0001525785,0.0003101761,0.001037434,0.0230807,0.00007989874,0.00290163,0.07625193],"study_design_scores_gemma":[0.5049669,0.4567762,0.03119929,0.00006150643,0.001098068,0.0002457908,0.00004888643,0.0009023632,0.002865613,0.000056856,0.001740255,0.00003836854],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930152,0.003482249,0.0004719498,0.0002460468,0.00009502545,0.001058928,0.0007357575,0.00005090412,0.0008439432],"genre_scores_gemma":[0.9914357,0.00225499,0.00142107,0.0007307868,0.000232589,0.001028939,0.001793381,0.00003566245,0.00106682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00667072,"threshold_uncertainty_score":0.0352785,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08825053625924434,"score_gpt":0.3294644849332314,"score_spread":0.241213948673987,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}